BioNote (377740.KS) Stock Price
BioNote Price
Revenue has compounded at 20.0% per year over the past 6 years to 118.04 B KRW. Earnings per share have grown at 22.4% per year over the last 5 years. BioNote's net margin stands at -74.1%, down from 108.7% several years earlier. BioNote currently offers a dividend yield of about 4.31%. Analysts set a median price target of 5,814.00 KRW, implying 25.2% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
BioNote stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
BioNote business model & stock analysis
Frequently asked questions about BioNote
Analysts currently set an average price target of 5,814.00 KRW for the BioNote stock (median: 5,814.00 KRW), implying +25.2 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the BioNote stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect BioNote to generate revenue of 196.62 B KRW and earnings per share of 314.49 KRW.
Converted at the current exchange rate, the BioNote share trades at 3.09 EUR (4,645.00 KRW).
The expected revenue of BioNote is 196.62 B KRW. This figure is based on current financial data and reflects the company's business performance.
The expected profit of BioNote is 31.74 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of BioNote is currently 14.77. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the BioNote stock.
The price-to-sales ratio (P/S) of BioNote is currently 2.38. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the BioNote stock.
The Eulerpool Quality Score for BioNote is 1/10.
The ISIN of BioNote is KR7377740006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of BioNote is 377740.KS. The ticker symbol is used to trade BioNote shares on the stock exchange.
BioNote stock
BioNote Peer Group
BioNote FIGI
All fundamentals and in-depth analysis of BioNote
Our stock analysis for BioNote stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioNote. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.